Angela Woodiwiss to Pentoxifylline
This is a "connection" page, showing publications Angela Woodiwiss has written about Pentoxifylline.
Connection Strength
0,545
-
Phosphodiesterase inhibition promotes the transition from compensated hypertrophy to cardiac dilatation in rats. Pflugers Arch. 2006 Jan; 451(4):526-33.
Score: 0,255
-
Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats. Eur J Pharmacol. 2005 May 09; 514(2-3):201-8.
Score: 0,062
-
A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension. S Afr Med J. 2004 Oct; 94(10):833-4.
Score: 0,059
-
C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2004 Oct; 6(6):731-4.
Score: 0,059
-
Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation. 2004 Feb 17; 109(6):750-5.
Score: 0,057
-
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2002 Nov 15; 90(10):1118-22.
Score: 0,052